Bipolar Research Today is a free monthly online journal that collates and summarizes the latest research about Bipolar, including details on bipolar disorder, symptoms, treatment, depression, medication.

Volume 5 (2008), Issue 5 (May)

1. Modulation of D-serine levels in brains of mice lacking PICK1.
   Biol Psychiatry, 63(10): 997-1000. [Abstract] [Full-text]
2. Increased brain d-amino acid oxidase (DAAO) activity in schizophrenia.
   Schizophr Res, 101(1): 76-83. [Abstract] [Full-text]
3. PDE4B polymorphisms and decreased PDE4B expression are associated with schizophrenia.
   Schizophr Res, 101(1): 36-49. [Abstract] [Full-text]
4. Who are the new users of antipsychotic medications?
   Psychiatr Serv, 59(5): 507-14. [Abstract] [Full-text]
5. Clinical differences between bipolar and unipolar depression.
   Br J Psychiatry, 192: 388-9. [Abstract] [Full-text]
6. The Moss Attention Rating Scale for traumatic brain injury: further explorations of reliability and sensitivity to change.
   Arch Phys Med Rehabil, 89(5): 966-73. [Abstract] [Full-text]
7. Mania profile in a community sample of prepubertal children in Turkey.
   Bipolar Disord, 10(4): 546-53. [Abstract] [Full-text]
8. Wisconsin Card Sorting Test performance in bipolar disorder: effects of mood state and early course.
   Bipolar Disord, 10(4): 539-45. [Abstract] [Full-text]
9. Comorbid anxiety in bipolar disorder: does it have an independent effect on suicidality?
   Bipolar Disord, 10(4): 530-8. [Abstract] [Full-text]
10. Social rhythm regularity and the onset of affective episodes in bipolar spectrum individuals.
    Bipolar Disord, 10(4): 520-9. [Abstract] [Full-text]
11. Impact of caregiver group psychoeducation on the course and outcome of bipolar patients in remission: a randomized controlled trial.
    Bipolar Disord, 10(4): 511-9. [Abstract] [Full-text]
12. Trauma exposure and posttraumatic stress disorder among primary care patients with bipolar spectrum disorder.
    Bipolar Disord, 10(4): 503-10. [Abstract] [Full-text]
13. Rapid cycling bipolar disorders in primary and tertiary care treated patients.
    Bipolar Disord, 10(4): 495-502. [Abstract] [Full-text]
14. Neuropsychological task performance in bipolar spectrum illness: genetics, alcohol abuse, medication and childhood trauma.
    Bipolar Disord, 10(4): 479-94. [Abstract] [Full-text]
15. Substance use disorders among adolescents with bipolar spectrum disorders.
    Bipolar Disord, 10(4): 469-78. [Abstract] [Full-text]
16. White matter abnormalities in bipolar disorder: a voxel-based diffusion tensor imaging study.
    Bipolar Disord, 10(4): 460-8. [Abstract] [Full-text]
17. Affective lability and affect intensity as core dimensions of bipolar disorders during euthymic period.
    Psychiatry Res, 159(1): 1-6. [Abstract] [Full-text]
18. Behavioral and gene expression analyses of Wfs1 knockout mice as a possible animal model of mood disorder.
    Neurosci Res, 61(2): 143-58. [Abstract] [Full-text]
19. A relationship between bipolar II disorder and borderline personality disorder?
    Prog Neuropsychopharmacol Biol Psychiatry, 32(4): 1022-9. [Abstract] [Full-text]
20. Complementary and alternative medicine in the treatment of bipolar disorder - A review of the evidence.
    J Affect Disord. [Abstract] [Full-text]
21. Effect of N-acetylcysteine and/or deferoxamine on oxidative stress and hyperactivity in an animal model of mania.
    Prog Neuropsychopharmacol Biol Psychiatry, 32(4): 1064-8. [Abstract] [Full-text]
22. Age-related cognitive decline in patients with mood disorders.
    Prog Neuropsychopharmacol Biol Psychiatry, 32(4): 962-7. [Abstract] [Full-text]
23. Defining mixed depression.
    Prog Neuropsychopharmacol Biol Psychiatry, 32(4): 932-9. [Abstract] [Full-text]
24. Antecedents and sequelae of sudden parental death in offspring and surviving caregivers.
    Arch Pediatr Adolesc Med, 162(5): 403-10. [Abstract] [Full-text]
25. Psychiatric use and utility of divalproex sodium in Connecticut prisons.
    Int J Offender Ther Comp Criminol, 52(3): 358-70. [Abstract] [Full-text]
26. Psychotic mania associated with mefloquine in a bipolar patient.
    South Med J, 101(5): 550-1. [Abstract] [Full-text]
27. Chronic Administration of Valproic Acid Reduces Brain NMDA Signaling via Arachidonic Acid in Unanesthetized Rats.
    Neurochem Res. [Abstract] [Full-text]
28. Perceptual switch rates with ambiguous structure-from-motion figures in bipolar disorder.
    Proc Biol Sci. [Abstract] [Full-text]
29. The prevalence of diabetes among sexual and violent offenders and its co-occurrence with cognitive impairment, mania, psychotic symptoms and aggressive behavior.
    Int J Prison Health, 4(2): 83-95. [Abstract] [Full-text]
30. Mood Stabilizing Drugs Expand the Neural Stem Cell Pool in the Adult Brain Through Activation of Notch Signaling.
    Stem Cells. [Abstract] [Full-text]
31. Support for Neuregulin 1 as a Susceptibility Gene for Bipolar Disorder and Schizophrenia.
    Biol Psychiatry. [Abstract] [Full-text]
32. Association of a Nonsynonymous Variant of DAOA with Visuospatial Ability in a Bipolar Family Sample.
    Biol Psychiatry. [Abstract] [Full-text]
33. Short-term psychodynamic psychotherapy: review of recent process and outcome studies.
    Aust N Z J Psychiatry, 42(6): 445-55. [Abstract] [Full-text]
34. Clinical epidemiology in patients admitted at Mathari Psychiatric Hospital, Nairobi, Kenya.
    Soc Psychiatry Psychiatr Epidemiol. [Abstract] [Full-text]
35. The impairment of pediatric bipolar sleep: hypotheses regarding a core defect and phenotype-specific sleep disturbances.
    J Affect Disord, 108(3): 199-206. [Abstract] [Full-text]
36. Abnormal corpus callosum myelination in pediatric bipolar patients.
    J Affect Disord, 108(3): 297-301. [Abstract] [Full-text]
37. Atypical symptoms in hospitalised patients with major depressive episode: frequency, clinical characteristics, and internal validity.
    J Affect Disord, 108(3): 271-8. [Abstract] [Full-text]
38. Age-dependent reduction of amygdala volume in bipolar disorder.
    Psychiatry Res, 163(1): 84-94. [Abstract] [Full-text]
39. Proton magnetic resonance spectroscopy in youth with severe mood dysregulation.
    Psychiatry Res, 163(1): 30-9. [Abstract] [Full-text]
40. Non-right-handedness is associated with migraine and soft bipolarity in patients with mood disorders.
    J Affect Disord, 108(3): 217-24. [Abstract] [Full-text]
41. Dissociative experiences differentiate bipolar-II from unipolar depressed patients: the mediating role of cyclothymia and the Type A behaviour speed and impatience subscale.
    J Affect Disord, 108(3): 207-16. [Abstract] [Full-text]
42. Anxiety is associated with impulsivity in bipolar disorder.
    J Anxiety Disord, 22(5): 868-76. [Abstract] [Full-text]
43. Screening for bipolar disorder in a county jail at the time of criminal arrest.
    J Psychiatr Res, 42(9): 778-86. [Abstract] [Full-text]
44. Theory of mind and social inference in children and adolescents with bipolar disorder.
    Psychol Med, 38(6): 791-800. [Abstract] [Full-text]
45. Proposed strategies for successful clinical management with aripiprazole.
    Expert Opin Pharmacother, 9(8): 1279-90. [Abstract] [Full-text]
46. A mutation in mouse Disc1 that models a schizophrenia risk allele leads to specific alterations in neuronal architecture and cognition.
    Proc Natl Acad Sci U S A, 105(19): 7076-81. [Abstract] [Full-text]
47. Dimensions of psychosis in patients with bipolar mania as measured by the positive and negative syndrome scale.
    Psychopathology, 41(4): 264-70. [Abstract] [Full-text]
48. Compelling or irrelevant? Using number needed to treat can help decide.
    Acta Psychiatr Scand, 117(6): 412-9. [Abstract] [Full-text]
49. A qualitative review of issues arising in the use of psycho-stimulant medications in patients with ADHD and co-morbid substance use disorders.
    Curr Med Res Opin, 24(5): 1345-57. [Abstract] [Full-text]
50. Polymorphisms in the GRIA1 gene region in psychotic bipolar disorder.
    Am J Med Genet B Neuropsychiatr Genet. [Abstract] [Full-text]
51. Cannabis and psychiatric disorders: it is not only addiction.
    Addict Biol, 13(2): 264-75. [Abstract] [Full-text]
52. Mode of action of mood stabilizers: is the arachidonic acid cascade a common target?
    Mol Psychiatry, 13(6): 585-96. [Abstract] [Full-text]
53. Whole-genome association study of bipolar disorder.
    Mol Psychiatry, 13(6): 558-69. [Abstract] [Full-text]
54. Suicide behavior and neuropsychological assessment of type I bipolar patients.
    J Affect Disord. [Abstract] [Full-text]
55. Comparison of mania patients suitable for treatment trials versus clinical treatment.
    Hum Psychopharmacol. [Abstract] [Full-text]
56. Psychoeducation for bipolar II disorder: An exploratory, 5-year outcome subanalysis.
    J Affect Disord. [Abstract] [Full-text]
57. Treatment costs and health care utilization for patients with bipolar disorder in a large managed care population.
    Value Health, 11(3): 416-23. [Abstract] [Full-text]
58. Self-reporting software for bipolar disorder: validation of ChronoRecord by patients with mania.
    Psychiatry Res, 159(3): 359-66. [Abstract] [Full-text]
59. A dimensional model of personality disorder: incorporating DSM Cluster A characteristics.
    J Abnorm Psychol, 117(2): 454-9. [Abstract] [Full-text]
60. Life events as predictors of mania and depression in bipolar I disorder.
    J Abnorm Psychol, 117(2): 268-77. [Abstract] [Full-text]
61. Borderline personality disorder and mood spectrum.
    Psychiatry Res, 159(3): 300-7. [Abstract] [Full-text]
62. Autism spectrum disorder scale scores in pediatric mood and anxiety disorders.
    J Am Acad Child Adolesc Psychiatry, 47(6): 652-61. [Abstract] [Full-text]
63. Neuropsychological Function and Dysfunction in Schizophrenia and Psychotic Affective Disorders.
    Schizophr Bull. [Abstract] [Full-text]
64. Carbon dioxide induces erratic respiratory responses in bipolar disorder.
    J Affect Disord. [Abstract] [Full-text]
65. A case-control association study of the PDLIM5 gene and bipolar disorder in a Sardinian sample.
    Psychiatr Genet, 18(3): 128-32. [Abstract] [Full-text]
66. PDLIM5 and susceptibility to bipolar disorder: a family-based association study and meta-analysis.
    Psychiatr Genet, 18(3): 116-21. [Abstract] [Full-text]
67. Analysis of protocadherin alpha gene deletion variant in bipolar disorder and schizophrenia.
    Psychiatr Genet, 18(3): 110-5. [Abstract] [Full-text]
68. Neuroactive steroids, mood stabilizers, and neuroplasticity: alterations following lithium and changes in Bcl-2 knockout mice.
    Int J Neuropsychopharmacol, 11(4): 547-52. [Abstract] [Full-text]
69. Association of functional polymorphisms in NOS1 and NOS3 with loudness dependence of auditory evoked potentials.
    Int J Neuropsychopharmacol, 11(4): 477-83. [Abstract] [Full-text]
70. Response to lithium of a cell surface ECTO-NOX protein with time-keeping characteristics.
    Neurosci Lett, 438(1): 121-5. [Abstract] [Full-text]
71. Primary leptomeningeal B-cell lymphoma of MALT-type in statu nascendi: A case report and review of the literature.
    Clin Neurol Neurosurg. [Abstract] [Full-text]
72. Moral objections to suicide and suicidal ideation among mood disordered Whites, Blacks, and Hispanics.
    J Psychiatr Res. [Abstract] [Full-text]
73. A double-blind, randomized, placebo-controlled prophylaxis trial of oxcarbazepine as adjunctive treatment to lithium in the long-term treatment of bipolar I and II disorder.
    Int J Neuropsychopharmacol, 11(4): 445-52. [Abstract] [Full-text]
74. Differential methylation of the X-chromosome is a possible source of discordance for bipolar disorder female monozygotic twins.
    Am J Med Genet B Neuropsychiatr Genet, 147(4): 459-62. [Abstract] [Full-text]
75. No association between prostate apoptosis response 4 gene (PAWR) in schizophrenia and mood disorders in a Japanese population.
    Am J Med Genet B Neuropsychiatr Genet, 147(4): 531-4. [Abstract] [Full-text]
76. Lithium response and genetic variation in the CREB family of genes.
    Am J Med Genet B Neuropsychiatr Genet, 147(4): 500-4. [Abstract] [Full-text]
77. A family history of psychopathology modifies the decrement in cognitive control among patients with HIV/AIDS.
    Brain Cogn, 67(1): 103-14. [Abstract] [Full-text]
78. Toxicity of lithium to humans and the environment--a literature review.
    Ecotoxicol Environ Saf, 70(3): 349-56. [Abstract] [Full-text]
79. Reduced expression of glyoxalase-1 mRNA in mood disorder patients.
    Neurosci Lett, 438(2): 196-9. [Abstract] [Full-text]
80. Comorbid anxiety in bipolar disorder alters treatment and prognosis.
    Psychiatr Q, 79(2): 139-50. [Abstract] [Full-text]
81. Differences between subjective and objective assessments of the utility of Electroconvulsive therapy in patients with bipolar and unipolar depression.
    J Affect Disord. [Abstract] [Full-text]
82. Screening for bipolar disorder: the utility and comparative properties of the MSS and MDQ measures.
    J Affect Disord, 109(1): 83-9. [Abstract] [Full-text]
83. Heterogeneity in cognitive functioning among patients with bipolar disorder.
    J Affect Disord, 109(1): 149-56. [Abstract] [Full-text]
84. Family history of suicidal behavior and early traumatic experiences: additive effect on suicidality and course of bipolar illness?
    J Affect Disord, 109(1): 57-63. [Abstract] [Full-text]
85. 5-ht2c receptor and mao-a interaction analysis: no association with suicidal behaviour in bipolar patients.
    Eur Arch Psychiatry Clin Neurosci. [Abstract] [Full-text]
86. Is the collaborative chronic care model effective for patients with bipolar disorder and co-occurring conditions?
    J Affect Disord. [Abstract] [Full-text]
87. The effectiveness of carbamazepine in unipolar depression: a double-blind, randomized, placebo-controlled study.
    J Affect Disord, 109(1): 91-7. [Abstract] [Full-text]
88. Chronic carbamazepine administration attenuates dopamine D2-like receptor-initiated signaling via arachidonic acid in rat brain.
    Neurochem Res, 33(7): 1373-83. [Abstract] [Full-text]
89. Diminished 5-HT functioning in CBCL pediatric bipolar disorder-profiled ADHD patients versus normal ADHD: susceptibility to rapid tryptophan depletion influences reaction time performance.
    Hum Psychopharmacol, 23(4): 291-9. [Abstract] [Full-text]
90. Astrocytic alkalinization by therapeutically relevant lithium concentrations: implications for myo-inositol depletion.
    Psychopharmacology (Berl). [Abstract] [Full-text]
91. Bipolar disorder: medication adherence and life contentment.
    Arch Psychiatr Nurs, 22(3): 113-26. [Abstract] [Full-text]
92. Towards further understanding of the co-morbidity between attention deficit hyperactivity disorder and bipolar disorder: a MRI study of brain volumes.
    Psychol Med, 38(7): 1045-56. [Abstract] [Full-text]
93. The long-term longitudinal course of oppositional defiant disorder and conduct disorder in ADHD boys: findings from a controlled 10-year prospective longitudinal follow-up study.
    Psychol Med, 38(7): 1027-36. [Abstract] [Full-text]
94. Minor physical anomalies in affective disorders. A review of the literature.
    J Affect Disord. [Abstract] [Full-text]
95. Gender differences in health-related quality of life for veterans with serious mental illness.
    Psychiatr Serv, 59(6): 663-9. [Abstract] [Full-text]
96. Attrition factors in clinical trials of comorbid bipolar and substance-related disorders.
    J Affect Disord. [Abstract] [Full-text]

© 2004-2008 Bipolar Research Today. All Rights Reserved.